Clinical Trial Update: A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating CLE-400 topical gel for chronic pruritus in adults with notalgia paresthetica has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Notalgia Paresthetica

Drugs mentioned

• CLE-400

Snippet

Sponsor: Clexio Biosciences Ltd. | Conditions: Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP) | Phase 2 | Status: COMPLETED | Results posted: 2025-11-18